Thermo Fisher Scientific Inc.

(NYSE:TMO)

Key Stats & Ratios

Valuation
Market Cap	14.67B
P/E	16.20
P/E (Trailing)	15.72
P/E (Forward)	—
Price/Sales	1.42
Price/Book	0.98
EPS	2.16
EPS Growth (ttm)	91.00%
Fiscal Year
Fiscal Year Ends	Dec 31
Last Quarter	Jun 2008
Profitability
Operating Income	1.19B
Net Income	943.80M
Profit Margin (ttm)	9.00%
Operating Margin (ttm)	0.11%
Management Effectiveness
Return on Assets (ttm)	4.40%
Return on Equity (ttm)	6.20%
EBIT Margin (ttm)	11.90
Memberships
S&P 500, Russel 1000, Fortune 500 Industrial
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value	15.80B
Revenue	10.47B
Revenue/Share	24.92
Revenue Growth (ytd)	10.20%
Annual Revenue Growth Rate (3Y)	60.76%
Annual Income Growth Rate (3Y)	14.10%
Earnings Growth (ytd)	35.00%
Gross Operating Profit (ttm)	4.97B
EBITDA	2.02B
Diluted EPS (ttm)	2.16
Balance Sheet
Total Cash	1.24B
Total Cash/Share	2.95
Total Assets	21.60B
Total Liabilities	6.46B
Total Debt/Equity	—
Long Term Debt Common Equity Ratio	0.13
Current Ratio	2.00
Leverage Ratio	1.00
Book Value/Share	36.02
Cash Flow
Cash Flow	1.74B
Free Cash Flow	650.50M
Cash Flow/Share	4.14
Free Cash Flow/Share	1.55

Trading Information